ArticleNeurospine2022

Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 in Multilevel Posterolateral Lumbar Fusion in a Prospective, Randomized, Controlled Trial.

Ho Yong Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.